New Zealand - English - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - peginterferon alfa-2b 150ug; ribavirin 200mg;   - combination - 200mg + 150µg - active: peginterferon alfa-2b 150ug excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polysorbate 80 sucrose water for injection active: ribavirin 200mg   excipient: croscarmellose sodium gelatin hydrated silica lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate tekprint blue sb-6018 titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - peginterferon alfa-2b 50ug; ribavirin 200mg;   - combination - 200mg + 50µg - active: peginterferon alfa-2b 50ug excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polysorbate 80 sucrose active: ribavirin 200mg   excipient: croscarmellose sodium gelatin hydrated silica ink lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate titanium dioxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - peginterferon alfa-2b 80ug; ribavirin 200mg;   - combination - 200mg + 80µg - active: peginterferon alfa-2b 80ug excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polysorbate 80 sucrose active: ribavirin 200mg   excipient: croscarmellose sodium gelatin hydrated silica lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate tekprint blue sb-6018 titanium dioxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

biotech pharmaceuticals (nz) pty limited - mebendazole 100mg; mebendazole 20 mg/ml - combination - active: mebendazole 100mg excipient: colloidal silicon dioxide hydrogenated vegetable oil magnesium stearate maize starch microcrystalline cellulose orange flavour 173126 purified talc purified water saccharin sodium sodium laurilsulfate sodium starch glycolate sunset yellow fcf active: mebendazole 20 mg/ml excipient: banana oil citric acid monohydrate dispersible cellulose as microcrystalline and sodium carmellose methyl hydroxybenzoate methylcellulose propyl hydroxybenzoate purified water sodium laurilsulfate sucrose

Australia - English - Department of Health (Therapeutic Goods Administration)

philips electronics australia ltd - 45143 - combination diagnostic imaging system, pet/ct - to perform ct studies, positron emission tomography studies or operate sequentially (dual-modality studies) wherein the pet and ct studies may be automatically co-registered and displayed in fused form.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - 45143 - combination diagnostic imaging system, pet/ct - to image and measure the distribution of injected positron emitting radiopharmaceuticals in humans and produce cross-sectional images of the body from either the same axial or spiral planes taken at different angles

Australia - English - Department of Health (Therapeutic Goods Administration)

philips electronics australia ltd - 45143 - combination diagnostic imaging system, pet/ct - a diagnostic imaging system that combines positron emission tomography (pet) and x-ray computed tomography (ct) systems. the ct subsystem produces cross-sectional images of the body by computer reconstruction of x-ray transmission data. the pet subsystem produces images of the distribution of pet radiopharmaceuticals in the patient body (specific radiopharmaceuticals are used for whole body, brain, heart and other organ imaging). ct data is applied to the pet data for attenuation correction. the pet subsystem also provides for list mode, dynamic, and gated acquisitions.

New Zealand - English - Ministry for Primary Industries

seneca holdings ltd - zinc; albendazole; selenium; copper; iodine; levamisole hydrochloride; cobalt - zinc 0.6 g/litre; albendazole 100 g/litre; selenium 0.9 g/litre; copper 2 g/litre; iodine 1 g/litre; levamisole hydrochloride 75 g/litre; cobalt 0.2 g/litre - endoparasiticide

Australia - English - Department of Health (Therapeutic Goods Administration)

philips electronics australia ltd - 45143 - combination diagnostic imaging system, pet/ct - a diagnostic imaging device that combines positron emission tomography (pet) and x-ray computed tomography (ct) systems. the ct subsystem images anatomical cross-sections by computer reconstruction of x-ray transmission data. the pet subsystem images the distribution of pet anatomy-specific radiopharmaceuticals in the patient. the pet/ct system is used for the purposes of detecting, localizing, diagnosing, staging, re-staging, and follow-up for monitoring therapy response of various diseases in oncology, cardiology, and neurology. the system is intended to image the whole body, heart, brain, lung, gastrointestinal, bone, lymphatic,and other major organs for a wide range of patient types, sizes, and extent of diseases. both subsystems can also be operated as fully functional, independent diagnostic tools, including application of the ct scanner for diagnosis and for use in radiation therapy planning.

Australia - English - Department of Health (Therapeutic Goods Administration)

canon medical systems anz pty ltd - 45143 - combination diagnostic imaging system, pet/ct - a diagnostic imaging system that combines positron emission tomography (pet) and x-ray computed tomography (ct) systems. the ct component produces cross-sectional images of the body by computer reconstruction of x-ray transmission data. the pet component images the distribution of pet radiopharmaceuticals in the patient body.